You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer

Authors

  • Yi-Fan Zhou Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yi Xiao Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Xi Jin Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Gen-Hong Di Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yi-Zhou Jiang Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Zhi-Ming Shao Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of ChinaInstitutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Zhi-Ming Shao; zhimingshao{at}yahoo.com; Dr Yi-Zhou Jiang; yizhoujiang{at}fudan.edu.cn; Dr Gen-Hong Di; genhongdi{at}163.com
View Full Text

Citation

Zhou Y, Xiao Y, Jin X, et al
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
Journal for ImmunoTherapy of Cancer 2021;9:e003371. doi: 10.1136/jitc-2021-003371

Publication history

  • Accepted August 29, 2021
  • First published October 6, 2021.
Online issue publication 
October 06, 2021

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.